
Biostate AI is a biotechnology company revolutionizing healthcare through next-generation RNA sequencing and artificial intelligence. They have developed proprietary RNA sequencing technologies that drastically reduce costs by 50-70%, enabling large-scale data collection essential for AI-driven personalized medicine. Their integrated platform includes RNA sequencing services, AI-powered bioinformatics tools like OmicsWeb, Copilot, and QuantaQuill, which democratize complex data analysis for researchers without specialized expertise. Biostate AI aims to build the world's largest RNA sequencing database to train foundation AI models that predict disease outcomes and treatment responses, ultimately enabling personalized therapeutics. The company serves academic labs, pharmaceutical R&D, biobanks, clinical oncology research, and biotech startups, positioning itself as a leader in affordable, AI-enhanced molecular diagnostics with a global presence and strategic partnerships with top medical institutions.

Biostate AI is a biotechnology company revolutionizing healthcare through next-generation RNA sequencing and artificial intelligence. They have developed proprietary RNA sequencing technologies that drastically reduce costs by 50-70%, enabling large-scale data collection essential for AI-driven personalized medicine. Their integrated platform includes RNA sequencing services, AI-powered bioinformatics tools like OmicsWeb, Copilot, and QuantaQuill, which democratize complex data analysis for researchers without specialized expertise. Biostate AI aims to build the world's largest RNA sequencing database to train foundation AI models that predict disease outcomes and treatment responses, ultimately enabling personalized therapeutics. The company serves academic labs, pharmaceutical R&D, biobanks, clinical oncology research, and biotech startups, positioning itself as a leader in affordable, AI-enhanced molecular diagnostics with a global presence and strategic partnerships with top medical institutions.
What they do: Proprietary low-cost RNA sequencing plus AI-driven multi-omics platform for biomarker discovery, disease prediction, and personalized medicine.
Founders & leadership: Co-founders David Zhang (Co‑Founder & CEO, Ph.D.) and Ashwin Gopinath (Co‑Founder & CTO).
Funding: $16M total raised; $12M Series A led by Accel (May 2025).
Core tech: Wet‑lab sequencing innovations (BIRT, PERD) and AI products including K‑Dense, N‑Act, OmicsWeb, Copilot, and QuantaQuill.
Locations: U.S. presence with Houston, TX (HQ/labs) and Palo Alto, CA (AI R&D).
Making transcriptomics scalable and actionable for research and clinical decision support by lowering sequencing costs and applying AI to multi‑omics data.
2023
Biotechnology Research
Seed round investors included Vision Plus Capital, Caltech, and angel investors such as Michael Schnall‑Levin, Emily Leproust, Joris Poort, and Dario Amodei.
12000000
Series A participation included Gaingels, Mana Ventures, Info Edge Ventures, Catapult Ventures, Vision Plus Capital, and Matter Venture Partners.
“Accel led the Series A; investors across rounds include institutional firms (Accel, Mana Ventures, Gaingels, Matter Venture Partners, Info Edge Ventures, Catapult Ventures, Vision Plus Capital) and individual/angel investors (including Dario Amodei, Emily Leproust, Michael Schnall‑Levin, Joris Poort).”
| Company |
|---|
Location:
Remote
About Biostate AI
Biostate AI is a biotechnology company advancing the predictive power of biology through high-throughput multi-omic data generation and AI-driven analysis. We collaborate with leading academic and clinical institutions to accelerate research and enable real-time biological insight at scale.
Role Overview
Biostate AI is seeking a creative and detail-oriented Digital Media Intern to help scale content operations and grow our digital presence. This role focuses on content planning, scripting, and coordination. The intern will help prepare platform-specific content (LinkedIn, X, TikTok, Reels, Shorts).
Responsibilities
Preferred Qualifications
Time Commitment
20 hours per week (flexible schedule)
Compensation (base + on target performance bonus)
$3,000 per month